Dual Vaccine Trial in Myeloproliferative Neoplasms

Clinical trial NCT04051307 · COMPLETED

Trial details

NCT number: NCT04051307
Sponsor: Inge Marie Svane
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Polycythemia Vera Essential Thrombocythemia

Start date: 2019-07-10
Primary completion: 2022-07-10
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.